Popularity #4,027Earnings are out
TLSA · NASDAQ · Biotechnology

Tiziana Life Sciences (ADR) (TLSA)

Develops intranasal anti-CD3 immunotherapy for neuroinflammatory and neurodegenerative diseases.

$1.03
vs last close+0.14 (+15.18%)
  1. Gemini Pro delay leaves Google with an empty flagship tier

    Proactive Investors - FinanceProduct